SECO annual meeting kicks off in New Orleans
The in-person event is scheduled for March 9-13 at the Ernest N. Morial Convention Center, with a SECO 2022 LIVE CE virtual meeting available to online attendees.
Théa completes eyecare expansion with Akorn's branded ophthalmic products
The purchase gives Théa ownership over seven products across the therapeutic space, including glaucoma and ocular surface disease.
Face coverings optional at Vision Expo East
Javits Center safety requirements updated in line with New York State and New York City guidelines.
Kala Pharmaceuticals: EYSUVIS now covered on UnitedHealthcare Commercial, Cigna Medicare
Effective this month, the coverage applies to approximately 70% of all United Healthcare commercial lives.
Optometry Times welcomes Black EyeCare Perspective to the Strategic Alliance Partnership (SAP) program
Black Eye Care Perspectives strives to creates awareness and change the narrative of optometry from a profession, provider, and patient perspective
6 daily habits destroying your eyes
These habits wreak havoc on your vision
GlassesUSA.com launches new “Vinyl Collection” by Ottoto
Each frame pays homage to the record player and the 1970s LA music scene
COVID-19 associated with a purtscher-like retinopathy
OCT showed inner retinal hyperreflectivity, diffuse retinal thickening with intraretinal fluid, and a serous macular detachment.
Poll results: Preferred treatment plans for mild-stage POAG
See our latest poll results
Orbis International celebrates 40 years of innovation
The nonprofit has continually reached for new heights in the fight against avoidable blindness.
FDA approves Johnson & Johnson's Acuvue Theravision with Ketotifen contact lens
Daily disposable contact lenses combine with an established antihistamine for the world's first drug-eluting contact lenses.
Essilor promotes new Crizal lens coating in the UK
The new anti-reflective lens coating outperforms its predecessors by up to 70%
Blackfin releases Spring-Summer 2022 collection
New line features reimagined optical styles with fresh new colors and sculpted shapes.
Aramis Biosciences doses first patient in phase 2 trial for DED treatment
Topline proof-of-concept data are expected by the first quarter of 2023.
CooperVision’s plastic neutral contact lens bank: 1-year results
In the past 12 months, the program has prevented the equivalent of 28 million plastics bottles from polluting the oceans.
Chronic bilateral dacryoadenitis related to COVID-19
SARS-CoV-2 may target lacrimal gland tissue and manifest as chronic inflammation
Oyster Point Pharma’s nasal spray for DED now covered by Express Scripts
TRYVAYA is the first and only FDA-approved nasal spray for the treatment of dry eye disease.
Shamir and Alpine extend esports strategic partnership
Shamir joined the Alpine in May 2021 in partnership with Alpine F1 Team to enhance the visual quality and safety of its race team members.
Orchestra eye injury
See this week's optical cartoon!
Poll results: What percentage of CE hours should ODs be able to take online?